The Competition Commission in South Africa has launched a formal investigation into leading insulin manufacturers Novo Nordisk and Sanofi Aventis following serious allegations of anti-competitive conduct. The inquiry was initiated after health activists complained about Novo Nordisk’s decision to cease supplying human insulin pens to the country’s Health Department in 2024. This move has forced thousands of diabetic patients to…